Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$183.69M
EBITDA Margin
-6455.53%
TTM Avg
-6455.53%
3Y Avg
-6455.53%
5Y Avg
-6455.53%
Market Cap
$183.55M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$181.30M
EBITDA Margin
-748.35%
TTM Avg
-748.35%
3Y Avg
-1092.82%
5Y Avg
-1042.94%
Market Cap
$189.50M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$178.83M
EBITDA Margin
-5219.12%
TTM Avg
-6964.15%
3Y Avg
-7000.85%
5Y Avg
-5161.09%
Market Cap
$192.29M
EBITDA Margin
-35.84%
TTM Avg
-29.80%
3Y Avg
-58.01%
5Y Avg
-110.32%
Market Cap
$193.27M
EBITDA Margin
-281.65%
TTM Avg
-281.65%
3Y Avg
-281.65%
5Y Avg
-281.65%
Market Cap
$173.76M
EBITDA Margin
-258.92%
TTM Avg
-202.75%
3Y Avg
-649.71%
5Y Avg
-1766.39%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | $184.94M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $183.69M | -6455.53% | -6455.53% | -6455.53% | -6455.53% |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.55M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.30M | -748.35% | -748.35% | -1092.82% | -1042.94% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.50M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $178.83M | -5219.12% | -6964.15% | -7000.85% | -5161.09% |
| RxSight, Inc. (RXST)vs › | $192.29M | -35.84% | -29.80% | -58.01% | -110.32% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $193.27M | -281.65% | -281.65% | -281.65% | -281.65% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -258.92% | -202.75% | -649.71% | -1766.39% |
| Journey Medical Corporation (DERM)vs › | $173.52M | -6.19% | -12.15% | -13.37% | -13.97% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
